Pre-formulation
In this course we will focus on how active compounds are developed into a formulation suitable for dosing in animal studies and early human clinical trials. Factors such as the route of administration, enhancing the solubility of the drug substance, the crystalline form of the drug substance, drug substance vs. drug product, storage requirements, and how special requirements of the patient population play a role in the design of an ideal formulation will be covered. Finally, some of the differences encountered when formulating a biologic vs. a small molecule will be discussed.
Target audience: This course is suitable for life scientists, clinicians, and individuals from fields that support drug discovery (e.g., patents, finance, licensing, etc.) interested in learning more about the pharmaceutical/biotechnology sector. Advanced undergraduate coursework or practical familiarity/working knowledge in biological sciences and organic chemistry is recommended.
Watch on Coursera ↗
(saves to browser)
Sign in to unlock AI tutor explanation · ⚡30
Related AI Lessons
⚡
⚡
⚡
⚡
When Should You Use Text2Cypher in a GraphRAG Pipeline
Dev.to AI
How to build a production RAG pipeline in Python (without a vector database)
Dev.to · Ayi NEDJIMI
Architecting Sub-150ms Hybrid RAG for Voice Agents: Combining pgvector, BM25, and Async FastAPI…
Medium · Python
Security Controls in Enterprise RAG: Keys, Audit Logs, and the Hierarchy That Prevents Role Elevation
Dev.to · Manjunath
🎓
Tutor Explanation
DeepCamp AI